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8 The recent ‘Brexit’ referendum result reminds us that behaviour is not simply determined by 9 
10 economic self-interest, yet the notion of paying physicians to perform remains remarkably 
11 popular. Medicare payments in the USA are increasingly linked to the quality of services, and 
12 
pay for the 32,000 UK general medical practitioners working for the National Health Service 
13 has been linked to quality of care through the Quality and Outcomes Framework (QOF) since 
14 2004.
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15 
16 Back then, quality indicators for general practice were new, and electronic medical records 
17 had become widespread in British general practice.3 The UK Department of Health wanted 
18 to improve population coverage of evidence based healthcare processes linked to improved 
19 
20 health outcomes, and invested £8 billion ($11 billion) over the first 3 years of QOF to reward 
21 performance in four areas: clinical, organisational, patient experience, and additional 
22 services. There were 80 clinical indicators in 2004 and 77 in 2016, covering cardiovascular 
23 disease, diabetes, respiratory disease, dementia, mental health, cancer, chronic kidney 
24 disease, epilepsy, learning disability, osteoporosis, rheumatoid arthritis, palliative care, 
25 obesity, smoking, cervical screening, and contraception.
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26 
27 Twenty-five of the original 80 indicators had research evidence for reduced mortality, and 
28 applying that evidence to the UK population showed that QOF had the potential to reduce 
29 
30 mortality by 11 lives per 100 000 people, as performance improved from baseline to the 
31 target for full payment.
5 
Twelve years later, Ryan et al measured the actual reduction in 
32 mortality, which turns out to be 12 per 100,000 (before correction for trends in similar 
33 countries) and 4 after correction (not statistically significant).
6 The authors point out that 
34 their analysis might be underpowered, but it is as good as we are likely to get and consistent 
35 with other findings.
6, 7 
QOF was not designed primarily to reduce population mortality, and 
36 
37 appears to have achieved pretty much exactly what was expected. 
38 What else have we learned from the first 12 years of QOF? No trials were conducted and the 39 
40 
evidence is weak, but clear benefits are the new source of publicly available population data 
41 
on major conditions, and the modest improvements seen in quality of care for chronic 
42 
diseases in the framework. However, quality improvement for non-incentivised conditions 
43 
such as osteoarthritis may have stagnated, continuity of care may have declined, and quality 
44 
improvement may have become too narrowly focused on QOF to the detriment of other 
45 
initiatives.
6, 8 
There are concerns that guidelines in general, and QOF in particular, risk 
46 
47 subverting patient-centred care, may inadvertently encourage unwanted polypharmacy and 
48 drug interactions as multimorbid older patients become the norm, and may have uncertain 
49 relevance to primary care patients.
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50 
51 QOF will become a teenager in 2017 and changes are needed. The focus should move from 
52 manipulating process measures such as blood glucose and lipid levels, to improving health in 
53 a way that has meaning for the individual patient. Examples of patient-centred quality 
54 measures include medication reconciliation after hospital discharge, and patient self- 
55 assessment of health status.
1 
Most patient-centred quality measures will be less directly 
56 
57 
under the physician’s control than current QOF indicators, and so caution will be needed if 
58 
payments are to be attached. Financial incentives in QOF are far larger than they need to be 
  
 
 
1 
2 
3 (one QOF point for 2016/17 is worth £165 ($223)) - indeed economists tell us that whilst 
4 financial incentives work for simple repetitive tasks they are ineffective for more complex 
5 tasks and may even be counterproductive.11 There is a case for abandoning QOF payments 
6 altogether and simply monitoring and reporting on quality at practice level, with the 
7 
8 resulting savings reallocated to the global sum for general practice. 
9 Applying population evidence to diverse individuals in primary care is difficult and uncertain, 
10 
11 and so needs to be guided by patient preferences as much as evidence. The National 
12 Institute for Health and Care Excellence (NICE) has the responsibility for managing QOF, and 
13 is developing guidance on multimorbidity and patient preferences that will be highly 
14 relevant. Good resources to share decisions on patients exist (eg http://optiongrid.org/), but 
15 more are needed and their routine use in practice needs to develop. QOF quality indicators 
16 should be accompanied by brief and clear decision aids about the benefits and risks of 17 
18 treatment options and the time to net benefit in cases where (small) harm is immediate and 
19 (greater) benefit delayed, to help combine evidence with patient preferences. QOF has the 
20 potential to lead the charge in the widespread implementation of patient-centred care to 
21 improve quality, if NICE have the will and courage to innovate and evaluate. 
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